• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
No Patient Left Behind: A Novel Paradigm to Fulfill Hepatitis C Virus Treatment for Rural Patients.不让任何患者掉队:为农村患者实现丙型肝炎病毒治疗的新范式。
Open Forum Infect Dis. 2024 Apr 26;11(5):ofae206. doi: 10.1093/ofid/ofae206. eCollection 2024 May.
2
Using Community Paramedicine to Treat Hepatitis C Virus in Upstate South Carolina.利用社区医疗模式治疗南卡罗来纳州北部的丙型肝炎病毒。
South Med J. 2023 Mar;116(3):321-325. doi: 10.14423/SMJ.0000000000001521.
3
Sustained virologic response from hepatitis C from an emergency department screening & linkage program: A retrospective review.从急诊科筛查和联系项目看丙型肝炎的持续病毒学应答:一项回顾性研究。
Am J Emerg Med. 2023 Oct;72:178-182. doi: 10.1016/j.ajem.2023.07.050. Epub 2023 Jul 29.
4
Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.柬埔寨农村地区丙型肝炎的分散检测和治疗:评估整合到现有公共卫生系统中的简化服务模式。
Lancet Gastroenterol Hepatol. 2021 May;6(5):371-380. doi: 10.1016/S2468-1253(21)00012-1. Epub 2021 Mar 19.
5
Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston.波士顿社区健康中心中曾有过无家可归经历的个体的丙型肝炎治疗结果。
Int J Drug Policy. 2019 Oct;72:129-137. doi: 10.1016/j.drugpo.2019.03.017. Epub 2019 Apr 6.
6
Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.格鲁吉亚全国丙型肝炎消除规划中接受索磷布韦为基础联合治疗的慢性丙型肝炎患者的治疗结局。
BMC Infect Dis. 2020 Jan 10;20(1):30. doi: 10.1186/s12879-019-4741-5.
7
Impact of the COVID-19 pandemic on hepatitis C outcomes at a health-system specialty pharmacy.COVID-19 大流行对医疗系统专科药房丙型肝炎治疗效果的影响。
J Manag Care Spec Pharm. 2022 Jun;28(6):667-672. doi: 10.18553/jmcp.2022.28.6.667.
8
Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients.在 COVID-19 应对期间,在注射毒品者的注射器服务项目中治疗丙型肝炎病毒:远程医疗、阿片类药物使用障碍治疗药物和对患者低要求的潜在作用。
Int J Drug Policy. 2022 Mar;101:103570. doi: 10.1016/j.drugpo.2021.103570. Epub 2021 Dec 20.
9
A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the "peer tele-HCV" study.一项针对农村地区吸毒人群的同伴促进远程医疗丙型肝炎治疗干预的随机对照试验:“同伴远程 HCV”研究的研究方案。
Addict Sci Clin Pract. 2023 May 27;18(1):35. doi: 10.1186/s13722-023-00384-z.
10
Twelve-week posttreatment follow-up to predict sustained virologic response for recurrent hepatitis C infection in liver recipients.肝移植受者复发性丙型肝炎感染持续病毒学应答的 12 周治疗后随访。
Transplantation. 2012 Feb 27;93(4):450-3. doi: 10.1097/TP.0b013e318240e9dd.

本文引用的文献

1
Facilitated telemedicine for hepatitis C virus: Addressing challenges for improving health and life for people with opioid use disorder.促进丙型肝炎的远程医疗:解决阿片类药物使用障碍患者改善健康和生活的挑战。
Health Expect. 2023 Dec;26(6):2594-2607. doi: 10.1111/hex.13854. Epub 2023 Aug 28.
2
Engaging people who use drugs in clinical research: integrating facilitated telemedicine for HCV into substance use treatment.让吸毒者参与临床研究:将丙型肝炎的辅助远程医疗纳入药物使用治疗。
Res Involv Engagem. 2023 Aug 2;9(1):63. doi: 10.1186/s40900-023-00474-x.
3
Community Paramedicine Intervention Reduces Hospital Readmission and Emergency Department Utilization for Patients with Cardiopulmonary Conditions.社区医疗干预可降低心肺疾病患者的住院再入院率和急诊就诊率。
West J Emerg Med. 2023 Jul 10;24(4):786-792. doi: 10.5811/westjem.57862.
4
Hepatitis C Elimination: Opportunities and Challenges in 2023.丙型肝炎消除:2023 年的机遇与挑战。
Viruses. 2023 Jun 22;15(7):1413. doi: 10.3390/v15071413.
5
Scaling and Sustaining Facilitated Telemedicine to Expand Treatment Access Among Underserved Populations: A Qualitative Study.扩大并持续推进便捷远程医疗以增加弱势群体的治疗可及性:一项定性研究
Telemed J E Health. 2023 Dec;29(12):1862-1869. doi: 10.1089/tmj.2022.0534. Epub 2023 May 26.
6
A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the "peer tele-HCV" study.一项针对农村地区吸毒人群的同伴促进远程医疗丙型肝炎治疗干预的随机对照试验:“同伴远程 HCV”研究的研究方案。
Addict Sci Clin Pract. 2023 May 27;18(1):35. doi: 10.1186/s13722-023-00384-z.
7
Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugs.在丙型肝炎治疗期间和之后的注射行为以及与未能治愈注射吸毒者的关系。
Drug Alcohol Depend. 2023 Jun 1;247:109878. doi: 10.1016/j.drugalcdep.2023.109878. Epub 2023 Apr 17.
8
Mobile Integrated Health Interventions for Older Adults: A Systematic Review.针对老年人的移动综合健康干预措施:一项系统综述。
Innov Aging. 2023 Mar 1;7(3):igad017. doi: 10.1093/geroni/igad017. eCollection 2023.
9
How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States.农村风险环境如何支撑丙型肝炎风险:美国伊利诺伊州南部农村的定性研究结果。
Int J Drug Policy. 2023 Feb;112:103930. doi: 10.1016/j.drugpo.2022.103930. Epub 2023 Jan 13.
10
High Satisfaction with Patient-Centered Telemedicine for Hepatitis C Virus Delivered to Substance Users: A Mixed-Methods Study.高满意度:以患者为中心的丙型肝炎病毒远程医疗服务在物质使用障碍患者中的应用:一项混合方法研究。
Telemed J E Health. 2023 Mar;29(3):395-407. doi: 10.1089/tmj.2022.0189. Epub 2022 Aug 4.

不让任何患者掉队:为农村患者实现丙型肝炎病毒治疗的新范式。

No Patient Left Behind: A Novel Paradigm to Fulfill Hepatitis C Virus Treatment for Rural Patients.

作者信息

Gormley Mirinda Ann, Moschella Phillip, Cordero-Romero Susan, Wampler Wesley R, Allison Marie, Kitzmiller Katiey, Estes Luke, Heo Moonseong, Litwin Alain H, Roth Prerana

机构信息

Department of Emergency Medicine, Prisma Health Upstate, Greenville, South Carolina, USA.

Department of Emergency Medicine, School of Medicine-Greenville, University of South Carolina, Greenville, South Carolina, USA.

出版信息

Open Forum Infect Dis. 2024 Apr 26;11(5):ofae206. doi: 10.1093/ofid/ofae206. eCollection 2024 May.

DOI:10.1093/ofid/ofae206
PMID:38737428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11088356/
Abstract

BACKGROUND

This study evaluates a novel multidisciplinary program providing expanded access to hepatitis C virus (HCV) treatment for rural Appalachian patients in South Carolina. This program identified patients via an opt-out emergency department screening program, and it aimed to achieve HCV cure by using community paramedics (CPs) to link and monitor patients from treatment initiation through 12-week sustained virologic response (SVR).

METHODS

Patients aged ≥18 years who were HCV RNA positive were eligible for enrollment if they failed to appear for a scheduled HCV appointment or reported barriers to accessing office-based treatment. CPs provided home visits (initial and 4, 12, and 24 weeks) using a mobile Wi-Fi hotspot to support telemedicine appointments (compliant with the Health Insurance Portability and Accountability Act) and perform focused physical assessments, venipuncture, and coordinated home delivery of medications. Statistics described participant characteristics, prevalence of SVR, and patient satisfaction results at 12 weeks posttreatment.

RESULTS

Thirty-four patients were eligible for SVR laboratory tests by 31 August 2023; the majority were male (61.7%) and White (64.7%) with an average age of 56 years (SD, 11.7). Twenty-eight (82.4%) completed treatment and achieved 12-week SVR. Six (17.6%) were lost to follow-up. Two-thirds strongly agreed that they were satisfied with the overall care that they received, and half strongly agreed that their overall health had improved.

CONCLUSIONS

This CP-augmented treatment program demonstrated success curing HCV for rural patients who lacked access to office-based treatment. Other health care systems may consider this novel delivery model to treat hard-to-reach individuals who are HCV positive.

摘要

背景

本研究评估了一项新型多学科项目,该项目为南卡罗来纳州阿巴拉契亚农村地区的患者提供了更多获得丙型肝炎病毒(HCV)治疗的机会。该项目通过退出式急诊科筛查项目识别患者,旨在通过社区护理人员(CP)从治疗开始到12周持续病毒学应答(SVR)对患者进行联系和监测,以实现HCV治愈。

方法

年龄≥18岁且HCV RNA呈阳性的患者,如果他们未按计划参加HCV预约或报告了获得门诊治疗的障碍,则有资格入选。CP使用移动Wi-Fi热点进行家访(初始家访以及第4、12和24周的家访),以支持远程医疗预约(符合《健康保险流通与责任法案》),并进行重点身体评估、静脉穿刺以及协调药物的家庭配送。统计数据描述了参与者特征、SVR患病率以及治疗后12周的患者满意度结果。

结果

截至2023年8月31日,34名患者有资格进行SVR实验室检测;大多数为男性(61.7%),白人(64.7%),平均年龄56岁(标准差,11.7)。28名(82.4%)完成治疗并实现了12周SVR。6名(17.6%)失访。三分之二的患者强烈同意他们对所接受的整体护理感到满意,一半的患者强烈同意他们的整体健康状况有所改善。

结论

这个由CP强化的治疗项目在治愈无法获得门诊治疗的农村患者的HCV方面取得了成功。其他医疗保健系统可能会考虑这种新型服务模式,以治疗难以接触到的HCV阳性个体。